The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

A previous version of this story had an incorrect title for Brian Dunkin. He is the chief medical officer of endoscopy at Boston Scientific. The story has been corrected. Millions of Americans have ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

WILMINGTON, N.C. (WECT) - A new weight loss option is now available for people seeking alternatives to weekly injections. The Wegovy pill became available on Monday, offering the first oral option for ...

The MarketWatch News Department was not involved in the creation of this content. CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

MUMBAI, Dec 24 (Reuters) - The latest intervention from the central bank through liquidity injection will ensure a sustained rise in government bond prices, as well as ensure banking system liquidity ...

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...

LOS ANGELES — A Glendale doctor is facing federal charges for allegedly submitting more than $45 million in bogus claims to Medicare for Botox injections that were medically unnecessary or never ...

W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...